Advertisement
Home Tags Drug Approvals

Tag: Drug Approvals

The first blood test designed to help health care professionals evaluate mild traumatic brain injury has been approved by the U.S. Food and Drug Administration.

FDA Approves First Blood Test to Evaluate Potential Concussions

Should help reduce unnecessary CT testing and associated radiation exposure
Erleada (apalutamide) has been approved by the U.S. Food and Drug Administration to treat non-metastatic

FDA Approves Erleada to Treat Non-Metastatic Prostate Cancer

First FDA-approved treatment for non-metastatic, castration-resistant prostate cancer
Admelog (insulin lispro)

FDA Approves Admelog for Diabetes

First drug approved as a follow-up product based on an abbreviated new process
A new once-weekly diabetes medication that lowers blood glucose and also helps patients lose weight has been approved by the U.S. Food and Drug Administration.

FDA Approves Ozempic for Type 2 Diabetes

Novo Nordisk drug also found to help with weight loss
Drugs with breakthrough status have the shortest median development time

Shortest Development Time for Breakthrough Status Drugs

Shorter development time for breakthrough, non-fast-track versus fast-track, non-breakthrough drugs
Sublocade

FDA Approves Once-Monthly Injection for Opioid Addiction

Sublocade has been shown to reduce opioid withdrawal symptoms and the desire to use opioids
Ogivri (trastuzumab-dkst) has been approved by the U.S. Food and Drug Administration as the nation's first biosimilar drug to treat certain breast and stomach cancers

FDA Approves Biosimilar Ogivri for Breast, Stomach Cancers

Ogivri is approved to treat HER2+ breast and gastric or gastroesophageal junction adenocarcinoma cancers
Hemlibra (emicizumab-kxwh) has been approved by the U.S. Food and Drug Administration to prevent or reduce the frequency of bleeding episodes among hemophilia A patients with Factor VIII inhibitors.

FDA OKs Drug for Hemophilia A With Factor VIII Inhibitors

Weekly prophylactic treatment associated with substantial decrease in bleeding episodes
The first drug in the United States with a digital ingestion tracking system has been approved by the U.S. Food and Drug Administration.

FDA Approves Drug With Digital Ingestion Tracking System

Aripiprazole tablets have embedded sensors so patients, physicians can track medication ingestion
Zelboraf (vemurafenib) has been approved by the U.S. Food and Drug Administration as the first drug to treat certain adults patients with Erdheim-Chester disease.

Zelboraf Approved for Use in Erdheim-Chester Disease

Kinase inhibitor (vemurafenib) for use in patients with BRAF V600 mutation